http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20011027-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
filingDate 2000-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e569734d4531cb381aaba0973c27b78
publicationDate 2001-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20011027-A1
titleOfInvention USE OF ACAT INHIBITORS TO REDUCE MONOCYT MACROPHAGUS ACCUMULATION AND MMP EXPRESSION IN ATHEROSCLEROTIC LESIONS
abstract IT REFERS TO THE USE OF AN INHIBITOR ACIL COENZYME A: ACYLTRANSFERASE CHOLESTEROL (ACAT) TO REDUCE THE ACCUMULATION OF MONOCYTES-MACROPHAGES AND THE EXPRESSION OF METALOPROTEASES (MMP) IN THE ATTEROSCLEROTIC PLATES USEFUL IN TRESATTABLE ANGLE; SUCH AS A COMPOUND OF FORMULA I WHERE X, Y ARE O, S, (CR'R ") n; n IS 1-4; R 'YR" ARE H, C1-C6 ALKYL, C1-C6 ALCOXY, C3- CYCLOALKYL C10, CARBONYL, AMONG OTHERS; R IS H, C1-C8 ALKYL, BENZYL; R1 AND R2 ARE PHENYL, PHENOXY; NAFTILO, ARYLALKYL; ADAMANTILO. PREFERRED COMPOUNDS are [[2,4,6-TRIS (1-METHYLETHYL) PHENYL] ACETYL] -2,6-BIS (1-METHYLETHYL) PHENYL ESTER OF SULPHAMIC ACID; (+/-) 2-DODECIL-O-PHENYL-N- (2,4,6-TRIMETOXIFENIL) -2H-TETRAZOLE-5-ACETAMIDE; (+/-) N- [2,6-BIS (1-METHYLETHYL) PHENYL] -2- (2-DODECIL-2H-TETRAZOL-5-IL) -2-PHENYL-ACETAMIDE, AMONG OTHERS
priorityDate 1999-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409381142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427267

Total number of triples: 43.